Files in This Item:
   
ThumbnailEUR_ICP_DRVE_94_01_MT01.pdf

View/Open

ThumbnailEUR_ICP_DRVE_94_01_MT01_rus.pdf

View/Open

Title: Clinical pharmacological evaluation in drug control : ensuring quality of clinical trials : report from the 19th European Symposium, Bad Neuenahr, Germany 12-13 December 1995
Authors: European Symposium on Clinical Pharmacological Evaluation in Drug Control (19th: 1995: Bad Neuenahr, Germany)
World Health Organization. Regional Office for Europe
Issue Date: 1996
Publisher: Copenhagen : WHO Regional Office for Europe
Language: English
German
Russian
Abstract: Clinical trials are an essential step in the development of safe and efficacious new drugs. Registration of new drugs in future could depend on mutual recognition of such trials. They must therefore be of high quality and adhere to high ethical standards. This can be assured through the application of good clinical practice procedures incorporating strict requirements for ethical conduct, quality assessment and high scientific standards. The personal rights of volunteers and patients in clinical trials must be protected. Countries with no experience of good clinical practice need to establish regulatory, biomedical and ethical standards as the basis for the necessary legislation
Description: EUR/ICP/DRVE 94 01/MT 01
23 p.
Subject: Pharmacology, Clinical
Drug and Narcotic Control
Quality Control
Clinical trials
Europe
metadata.dc.subject.other: Pharmaceuticals and Biologicals
Gov't Doc #: EUR/ICP/DRVE 94 01/MT 01
URI: http://www.who.int/iris/handle/10665/107540
Appears in Collections:Technical documents



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.